These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36148941)

  • 1. Effectiveness of remdesivir with corticosteroids for COVID-19 patients in intensive care unit: A hospital-based observational study.
    Hanafusa M; Nawa N; Goto Y; Kawahara T; Miyamae S; Ueki Y; Nosaka N; Wakabayashi K; Tohda S; Tateishi U; Fujiwara T
    J Med Virol; 2023 Jan; 95(1):e28168. PubMed ID: 36148941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.
    Hussain Alsayed HA; Saheb Sharif-Askari F; Saheb Sharif-Askari N; Hussain AAS; Hamid Q; Halwani R
    PLoS One; 2021; 16(10):e0258643. PubMed ID: 34699552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
    Alonso-Navarro R; Ramírez M; Masiá M; Paredes R; Montejano R; Povar-Echeverria M; Carratalà J; Salavert M; Bernal E; Dueñas C; Flores J; Fanjul F; Gutiérrez I; Rico V; Mateu L; Cadiñanos J; Berenguer J; Soriano A
    BMC Infect Dis; 2023 May; 23(1):286. PubMed ID: 37142994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
    Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
    PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in Germany.
    Marx K; Gončarova K; Fedders D; Kalbitz S; Kellner N; Fedders M; Lübbert C
    Infection; 2023 Feb; 51(1):97-108. PubMed ID: 35553032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
    Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
    PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements.
    Tortajada C; Colomer E; Andreu-Ballester JC; Esparcia A; Oltra C; Flores J
    J Med Virol; 2021 Mar; 93(3):1817-1823. PubMed ID: 33107607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Stage Combination Treatment with Methylprednisolone Pulse and Remdesivir for Severe COVID-19 Pneumonia.
    Mastruzzo C; Commodari E; Grasso U; La Rosa VL; Balsamo D; Circo C; Oliveri R
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis.
    Lee TC; McDonald EG; Butler-Laporte G; Harrison LB; Cheng MP; Brophy JM
    Int J Infect Dis; 2021 Mar; 104():671-676. PubMed ID: 33540128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients.
    Coelho L; Falcão F; Póvoa P; Viegas E; Martins AP; Carmo E; Fonseca C; Campos L; Mansinho K; Carmo I; Soares J; Solano M; Mendes D; Miranda AC; Carvalho A; Mirco A; Farinha H; Aldir I; Correia J
    Sci Rep; 2023 Mar; 13(1):4482. PubMed ID: 36934143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Corticosteroids on Mortality in Hospitalized COVID-19 Patients Not Receiving Invasive Mechanical Ventilation.
    Fusina F; Albani F; Granato E; Meloni A; Rozzini R; Sabatini T; Stellini R; Terragnoli P; Rosano A; Abu Hilal M; Natalini G
    Clin Pharmacol Ther; 2021 Jun; 109(6):1660-1667. PubMed ID: 33792037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score.
    Sellers J; Chang J; Jones J; Hintze TD
    Pulm Pharmacol Ther; 2023 Feb; 78():102188. PubMed ID: 36603741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evolution and mortality of critically ill patients with SARS-CoV-2 pneumonia treated with remdesivir in an adult intensive care unit of Paraguay.
    Figueredo J; Lopez LF; Leguizamon BF; Samudio M; Pederzani M; Apelt FF; Añazco P; Caballero R; Bianco H
    BMC Infect Dis; 2024 Jan; 24(1):37. PubMed ID: 38166777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study.
    Mengato D; Mazzitelli M; Francavilla A; Bettio M; Sasset L; Presa N; Pivato L; Lo Menzo S; Trevenzoli M; Venturini F; Gregori D; Cattelan AM
    Clin Exp Med; 2023 Oct; 23(6):2749-2756. PubMed ID: 36961678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world use of remdesivir for the treatment of patients admitted to Italian hospitals with COVID-19: the nationwide retrospective FADOI-RECOVER study.
    Pieralli F; Pomero F; Dentali F; Norbiato C; Attardo T; Vicari S; Magnani E; Marzilli MA; Piccolo P; Valerio A; Manfellotto D;
    BMC Infect Dis; 2023 Jul; 23(1):454. PubMed ID: 37422621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.